Dr. Sripathi R. Kethu, MD

Dr. Kethu practices at Texas Digestive Disease Consultants in Richardson, Texas.

Dr. Kethu's NPI, 1801840111, was assigned on May 20, 2006. Dr. Kethu holds Texas license M6699.

Dr. Kethu's primary practice is Texas Digestive Disease Consultants, at 2821 E President George Bush Hwy, Richardson, TX 75082 in Dallas County. The practice phone is (972) 691-3777.

Dr. Kethu's primary practice is Texas Digestive Disease Consultants in Richardson, Texas. Dr. Kethu is also affiliated with Methodist Richardson Medical Center. The medical group on file is Texas Digestive Disease Consultants. Dmand AI also links Dr. Kethu to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kethu practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Kethu's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Kethu is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Kethu's licenses on file in 4 states: Texas, Georgia, Rhode Island and Illinois.

Dmand AI lists acid reflux, chronic indigestion, cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids and hepatitis c among the conditions Dr. Kethu treats.

CMS data shows 753 Medicare services from Dr. Kethu across 16 procedure codes in 2024, for 487 Medicare patients. Medicare paid $74,498 for them.

CMS counts 487 Medicare patients who saw Dr. Kethu in 2024. The largest group is 65 to 74, with 283 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kethu's median patient age at 62, with 45% women.

In 2024, Dr. Kethu wrote 494 Medicare Part D claims for 231 patients. 82% of them were for generic drugs. CMS names the drug for 368 of them, across 9 drugs with 11 or more claims each, at $12,134 in total drug cost. In 2023, CMS named 279 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Kethu for performance year 2024, reported as part of a group. Dr. Kethu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kethu as offering telehealth. CMS counts 161 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Kethu, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 21 papers to Dr. Kethu, published from 2006 to 2011. 2011 was the busiest year, with 4. The most frequent topics are Equipment Design, Endoscopes, Gastrointestinal and Endoscopy, Gastrointestinal. Dr. Kethu has published most often in Gastrointest Endosc. Dr. Kethu's most frequent co-authors are Petar Mamula, MD, Subhas Banerjee, MD and David J. Desilets, MD.

CMS Open Payments shows 621 general payments to Dr. Kethu from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Abbvie Inc. paid the most, $4,219.

Dmand AI lists 4 awards for Dr. Kethu, most recently Voted Best Doctors in Dallas in 2019.

Dr. Kethu is a member of ACG.

Dr. Kethu is in network with 21 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.